Charles River (CRL) Q1 Earnings on the Horizon: Analysts' Insights on Key Performance Measures

Wall Street analysts expect Charles River Laboratories (CRL) to post quarterly earnings of $2.05 per share in its upcoming report, which indicates a year-over-year decline of 26.3%. Revenues are expected to be $997.24 million, down 3.1% from the year-ago quarter.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.Ahead of a company's earnings disclosure, i ...